Literature DB >> 18185523

MicroRNA expression in lymphocyte development and malignancy.

C H Lawrie, N J Saunders, S Soneji, S Palazzo, H M Dunlop, C D O Cooper, P J Brown, X Troussard, H Mossafa, T Enver, F Pezzella, J Boultwood, J S Wainscoat, C S R Hatton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18185523     DOI: 10.1038/sj.leu.2405083

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  40 in total

Review 1.  Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation.

Authors:  Liqin Du; Alexander Pertsemlidis
Journal:  J Mol Cell Biol       Date:  2011-01-28       Impact factor: 6.216

Review 2.  Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias.

Authors:  Sho Ikeda; Hiroyuki Tagawa
Journal:  Int J Hematol       Date:  2014-02-25       Impact factor: 2.490

3.  Unified translation repression mechanism for microRNAs and upstream AUGs.

Authors:  Subramanian S Ajay; Brian D Athey; Inhan Lee
Journal:  BMC Genomics       Date:  2010-03-05       Impact factor: 3.969

4.  MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.

Authors:  Erica Ballabio; Tracey Mitchell; Marloes S van Kester; Stephen Taylor; Heather M Dunlop; Jianxiang Chi; Isabella Tosi; Maarten H Vermeer; Daniela Tramonti; Nigel J Saunders; Jacqueline Boultwood; James S Wainscoat; Francesco Pezzella; Sean J Whittaker; Cornelius P Tensen; Christian S R Hatton; Charles H Lawrie
Journal:  Blood       Date:  2010-05-06       Impact factor: 22.113

5.  MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma.

Authors:  Cuiling Liu; Javeed Iqbal; Julie Teruya-Feldstein; Yulei Shen; Magdalena Julia Dabrowska; Karen Dybkaer; Megan S Lim; Roberto Piva; Antonella Barreca; Elisa Pellegrino; Elisa Spaccarotella; Cynthia M Lachel; Can Kucuk; Chun-Sun Jiang; Xiaozhou Hu; Sharathkumar Bhagavathi; Timothy C Greiner; Dennis D Weisenburger; Patricia Aoun; Sherrie L Perkins; Timothy W McKeithan; Giorgio Inghirami; Wing C Chan
Journal:  Blood       Date:  2013-06-25       Impact factor: 22.113

6.  Epstein-Barr virus growth/latency III program alters cellular microRNA expression.

Authors:  Jennifer E Cameron; Claire Fewell; Qinyan Yin; Jane McBride; Xia Wang; Zhen Lin; Erik K Flemington
Journal:  Virology       Date:  2008-10-31       Impact factor: 3.616

7.  ATM is down-regulated by N-Myc-regulated microRNA-421.

Authors:  Hailiang Hu; Liutao Du; Gindy Nagabayashi; Robert C Seeger; Richard A Gatti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

8.  The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update.

Authors:  Raymond Lai; Robert J Ingham
Journal:  Ther Adv Hematol       Date:  2013-04

9.  MicroRNA-26a-mediated regulation of interleukin-2 expression in transformed avian lymphocyte lines.

Authors:  Hongtao Xu; Yongxiu Yao; Lorraine P Smith; Venugopal Nair
Journal:  Cancer Cell Int       Date:  2010-05-04       Impact factor: 5.722

10.  Global changes in processing of mRNA 3' untranslated regions characterize clinically distinct cancer subtypes.

Authors:  Priyam Singh; Travis L Alley; Sarah M Wright; Sonya Kamdar; William Schott; Robert Y Wilpan; Kevin D Mills; Joel H Graber
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.